Archive for July 20th, 2007

Starting position in SIRF Technologies

On July 16 I purchased 215 shares of SIRF at 23.27.

“SiRF Technology Holdings, Inc. (SiRF) is a supplier of global positioning system (GPS) semiconductor solutions designed to provide location awareness capabilities in high-volume mobile consumer and commercial applications. SiRF offers a range of GPS chip sets and software products for high-volume GPS markets.”

Basically they make the GPS chips that will fit in small handheld devices such as mobile phones.  And that sounds like a market that will go up, up, up!

At least I hope… their stock price has been rather volatile.

I also made my first stock option purchase (also with SIRF).  Call options costing 1.60 expiring on September 22 at 25.  Thought it was time to get my feet wet in the options sea.

On a sidenote, Microsoft Money is demonstrating some weird glitch where stocks that are at a gain are showing a loss on the portfolio.  What a terrible bug!

Rise in value of office space in Singapore is highest in the world

From Straits Times – July 20, 2007:

By Fiona Chan, Property Reporter

SINGAPORE’S office buildings have shot up in value by more than anywhere else in the world over the past year.

These soaring values, as well as a rush of investment capital into Singapore, have made the property market here the world’s hottest.

This was revealed by property firm Jones Lang LaSalle (JLL) earlier this week, ahead of a fuller report on global real estate investment due out next month. It will track property deals above US$5 million (S$6.5 million) worldwide, most of which involve commercial real estate, such as offices and shops.

JLL’s head of Asia capital markets, Mr Stuart Crow, elaborated on the preliminary findings yesterday.

He told The Straits Times that capital values of property in Singapore, particularly offices, have risen the most in the world in terms of a straight monetary increase rather than a percentage rise.

In the prime Raffles Place area, office values rose by US$804 per sq ft (psf) in the last 12 months, boosted by a supply crunch and soaring rentals. This is more than double the increase in Hong Kong’s central district, where offices rose about US$280 psf in value on average, he said.

In percentage terms, Singapore’s office values jumped a staggering 105 per cent in a year to reach $1,568.50 psf last month.

In Hong Kong, values rose only 16.7 per cent in the same period to hit US$1,958.60 psf. But Mumbai’s growth beat Singapore’s in percentage terms – up 123 per cent to US$1,166.20 psf.

Office values in Singapore have been driven up by an acute supply crunch as well as soaring demand from expanding businesses. But some experts have warned that rising office prices and rent could hurt the Republic’s competiveness.

The surge in real estate values here has also been boosted by buzzing investor interest in Singapore, said Mr Crow.

In the first half of this year, US$3.7 billion worth of real estate changed hands here – a 40 per cent jump from a year earlier and the fourth highest figure in the Asia-Pacific region, behind Japan, Australia and China.

Mr Crow believes property investments here will double in the next six months to reach about US$8 billion for the whole year. ‘We’re still in the early stages. Next year, investment flows may strengthen even further.’

He said many new foreign players have arrived in Singapore’s real estate market, adding that it has been transformed from an ‘opportunistic’ destination to a ‘core market’.

Of the last 18 major office transactions in Singapore, 16 have involved foreign buyers, noted Mr Crow. About 11 of these were making their first acquisition in Singapore; for some, their first in Asia.

British-based property fund Develica, for one, bought its first Asian building last month, 1 Finlayson Green, for $231 million.

fiochan@sph.com.sg

Started position in Baxter International (BAX)

And boy do I wish I hadn’t.

Back on July 14 I bought 100 shares of BAX at 58.49.  They are a medical products and services company that target a range of diseases (hemophilia, kidney disease, cancer, etc.)

Their fundamentals looked solid, stock price was on the up and up…

And then today they announced earnings.  Where they surpassed the estimates and raised their guidance for the full year.  Second quarter profit grew by 39%.

Sounds rosy.

Alas, late Wednesday the FDA classified a recall on one of Baxter’s pump devices.  A “Class 1 recall” which is apparently for dangerous or defective products that could cause serious health problems or death.  Baxter’s CEO (Robert L. Parkinson) says that the recall will have no material effect on the finances.

It looks like the stock market disagrees.

And now Baxter is trading at 56.00.  Ouch.  I’ll keep holding… for now…

Follow

Get every new post delivered to your Inbox.